183 related articles for article (PubMed ID: 34957746)
21. [Why use long-term macrolide therapy in pediatric pulmonology?].
Corvol H; Taytard J; Thouvenin G; Périsson C; Nathan N; Clement A
Arch Pediatr; 2014 Mar; 21(3):314-21. PubMed ID: 24503457
[TBL] [Abstract][Full Text] [Related]
22. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
Chalmers JD; Boersma W; Lonergan M; Jayaram L; Crichton ML; Karalus N; Taylor SL; Martin ML; Burr LD; Wong C; Altenburg J
Lancet Respir Med; 2019 Oct; 7(10):845-854. PubMed ID: 31405828
[TBL] [Abstract][Full Text] [Related]
23. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.
Altenburg J; de Graaff CS; Stienstra Y; Sloos JH; van Haren EH; Koppers RJ; van der Werf TS; Boersma WG
JAMA; 2013 Mar; 309(12):1251-9. PubMed ID: 23532241
[TBL] [Abstract][Full Text] [Related]
24. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
King P
Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
[TBL] [Abstract][Full Text] [Related]
25. Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational study.
Coeman M; van Durme Y; Bauters F; Deschepper E; Demedts I; Smeets P; Joos G; Brusselle G
Ther Adv Respir Dis; 2011 Dec; 5(6):377-86. PubMed ID: 21890536
[TBL] [Abstract][Full Text] [Related]
26. Macrolides for chronic asthma.
Kew KM; Undela K; Kotortsi I; Ferrara G
Cochrane Database Syst Rev; 2015 Sep; (9):CD002997. PubMed ID: 26371536
[TBL] [Abstract][Full Text] [Related]
27. Macrolide antibiotics for cystic fibrosis.
Southern KW; Barker PM; Solis-Moya A; Patel L
Cochrane Database Syst Rev; 2011 Dec; (12):CD002203. PubMed ID: 22161368
[TBL] [Abstract][Full Text] [Related]
28. Azithromycin: mechanisms of action and their relevance for clinical applications.
Parnham MJ; Erakovic Haber V; Giamarellos-Bourboulis EJ; Perletti G; Verleden GM; Vos R
Pharmacol Ther; 2014 Aug; 143(2):225-45. PubMed ID: 24631273
[TBL] [Abstract][Full Text] [Related]
29. The immunomodulatory effects of macrolide antibiotics in respiratory disease.
Pollock J; Chalmers JD
Pulm Pharmacol Ther; 2021 Dec; 71():102095. PubMed ID: 34740749
[TBL] [Abstract][Full Text] [Related]
30. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
Cameron EJ; McSharry C; Chaudhuri R; Farrow S; Thomson NC
Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
[TBL] [Abstract][Full Text] [Related]
31. A systematic review and meta-analysis of macrolides in the management of adult patients with asthma.
Ohnishi H; Otani T; Kanemitsu Y; Nagano T; Hara J; Eitoku M
Allergol Int; 2024 Jul; 73(3):382-389. PubMed ID: 38296770
[TBL] [Abstract][Full Text] [Related]
32. Macrolide antibiotics in the treatment of asthma. An update.
Hernando-Sastre V
Allergol Immunopathol (Madr); 2010; 38(2):92-8. PubMed ID: 20171003
[TBL] [Abstract][Full Text] [Related]
33. A review of non-cystic fibrosis bronchiectasis in children with a focus on the role of long-term treatment with macrolides.
El Boustany P; Gachelin E; Colomban C; Cernoia J; Sudour P; Carsin A; Dubus JC
Pediatr Pulmonol; 2019 Apr; 54(4):487-496. PubMed ID: 30652424
[TBL] [Abstract][Full Text] [Related]
34. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
López-Boado YS; Rubin BK
Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
36. The role of macrolides in asthma: current evidence and future directions.
Wong EH; Porter JD; Edwards MR; Johnston SL
Lancet Respir Med; 2014 Aug; 2(8):657-70. PubMed ID: 24948430
[TBL] [Abstract][Full Text] [Related]
37. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.
Zarogoulidis P; Papanas N; Kioumis I; Chatzaki E; Maltezos E; Zarogoulidis K
Eur J Clin Pharmacol; 2012 May; 68(5):479-503. PubMed ID: 22105373
[TBL] [Abstract][Full Text] [Related]
38. Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis.
Sharma S; Jaffe A; Dixon G
Paediatr Drugs; 2007; 9(2):107-18. PubMed ID: 17407366
[TBL] [Abstract][Full Text] [Related]
39. Macrolides in cystic fibrosis: is there a role?
Wolter JM; Seeney SL; McCormack JG
Am J Respir Med; 2002; 1(4):235-41. PubMed ID: 14720043
[TBL] [Abstract][Full Text] [Related]
40. Macrolides in the treatment of asthma and cystic fibrosis.
Ferrara G; Losi M; Franco F; Corbetta L; Fabbri LM; Richeldi L
Respir Med; 2005 Jan; 99(1):1-10. PubMed ID: 15672842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
